NCT04874155 - Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) | Biotech Hunter

Enrollment

133

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

March 18, 2022

Study Completion Date

April 8, 2022

Conditions

Restless Legs Syndrome

Interventions

DEVICE

NTX100 Neuromodulation System - Active

Noninvasive peripheral nerve stimulation device programmed to active mode.

DEVICE

NTX100 Neuromodulation System - Sham

Noninvasive peripheral nerve stimulation device programmed to sham mode.

DEVICE

NTX100 Neuromodulation System - Open-Label

Noninvasive peripheral nerve stimulation device programmed to active mode.

Trial Locations (7)

Bogan Sleep Consultants, LLC, Columbia

Neurotrials Research, Atlanta

Ohio Sleep Medicine Institute, Dublin

Clayton Sleep Institute, St Louis

FutureSearch Trials of Neurology, Austin

California Center for Sleep Disorders, San Leandro

Delta Waves, Inc., Colorado Springs